GPI
Pill imprint GPI has been identified as Docusate sodium sodium 100 mg.
Docusate is used in the treatment of constipation and belongs to the drug class laxatives. FDA has not classified the drug for risk during pregnancy.
Docusate sodium 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Docusate sodium Images
- Imprint:
-
GPI
- Strength:
- sodium 100 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Laxatives
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Major Pharmaceuticals Inc.
More Docusate Sodium resources
- Docusate (Wolters Kluwer)
- Docusate Enema (Wolters Kluwer)
- Docusate Liquid (Wolters Kluwer)
- Docusate Syrup (Wolters Kluwer)
- docusate (Cerner Multum)
- Docusate Sodium (FDA)
- Docusate (Wolters Kluwer)


